Clinical Trial Update: A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of CBP-307 in adults with moderate to severe ulcerative colitis has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• CBP-307

Snippet

Sponsor: Connect Biopharm LLC | Conditions: Moderate to Severe Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2023-11-02